Prosiectau (583)
Cardiff University Schools involved in this Project
Understanding the biomechanics of human skin tissue and micro-disruption of the skin barrier by transdermal delivery systems (TDS), such as the microneedle array device (MD) (01.06.2010 - 31.05.2011)
- Coulman, Sion
Understanding the association between E-cadherin loss and adverse response to endocrine agents in ER+ breast cancer (01.01.2015 - 31.01.2016)
- Hiscox, Stephen
Understanding how formulation parameters influence the performance of novel capsule formulations (01.07.2024 - 30.06.2027)
- Coulman, Sion
Understanding how ageing and the female gender contribute to mitochondrial dysfunction and the development of Alzheimer's disease (01.10.2019 - 31.03.2022)
- Kidd, Emma
Understanding how age and gender influence the development of Alzheimer's disease (01.10.2018 - 30.09.2021)
- Kidd, Emma
Treating progressive multiple sclerosis using a novel neuroprotective and anti-inflammatory approach (01.10.2015 - 15.11.2018)
- Mcguigan, Christopher
Translation of bacterial mediated therapeutic RNAi of solid tumours by demonstrating PARP inhibition in preclinical trials (30.06.2018 - 15.11.2018)
- Brancale, Andrea
-
- Smith, Mathew
Trace amines for restoring blood pressure and organ perfusion in sepsis (01.04.2022 - 31.03.2025)
- Ford, William
Towards validation of an immune suppressor protein from liver fluke as a drug target (01.10.2015 - 30.09.2018)
- Mcguigan, Christopher
Towards the repurposing of existing topical antimicrobials by ligand complexation (01.10.2015 - 25.01.2019)
- Heard, Charles
Towards the commercialisation of dual action mucoadhesive patches to treat periodontal disease (01.02.2017 - 31.01.2018)
- Heard, Charles
Towards devising a therapeutic strategy for patients with RRM2B-related mitochondrial (15.06.2018 - 31.07.2021)
- Mehellou, Youcef
Towards a nanomedicine-based broad-spectrum topical virucidal therapeutic system (01.10.2007 - 31.01.2011)
- Heard, Charles
Towards a magneto-optical sensor for sepsis (01.07.2012 - 26.08.2012)
- Allender, Christopher
To reduce microbial contamination on surfaces and infection by developing novel and effective antimicrobial surfaces (21.01.2019 - 17.03.2022)
- Maillard, Jean-Yves
To provide analytical and microscopy services, analysis of the components of surgical smoke generated by the use of diathermy (01.03.2015 - 30.04.2015)
- Birchall, James
Topical delivery of Melatonin Derivatives (01.06.2009 - 30.09.2009)
- Heard, Charles
To examine the action of R 1507 in a range of breast cancer models reflective of endocrine response and failure (01.09.2008 - 31.03.2010)
- Hutcheson, Iain
To evaluate the in-vitro potential of locally applied antibiotics to cause the development of bacterial resistance (02.01.2018 - 30.09.2018)
- Maillard, Jean-Yves
To embed expertise on the development of novel biochemical reagents to pathogens and exploit this knowledge to develop point-of-care products for the healthcare sector (07.06.2010 - 06.06.2012)
- Baillie, Les
To develop new biocidal products with efficacy particularly against mycobacteria and non-enveloped viruses (01.11.2016 - 31.12.2019)
- Maillard, Jean-Yves
To carry out experiments to investigate the diffusion of budesonide across ocular membranes (01.06.2010 - 31.05.2012)
- Allender, Christopher
Tissue engineering for human healing (12.04.2010 - 13.10.2011)
- Jones, Arwyn
The use of 3D culture to test the efficacy of a novel enzyme for cancer pro-drug therapy (01.02.2016 - 31.07.2016)
- Mcguigan, Christopher